Molecular Otolaryngology and Renal Research Laboratories |

Featured Content

Uncontrolled complement activity drives many diseases including two ultra-rare renal diseases. MORL provides a metric to follow a patient’s clinical course. MORL Clinical Testing Menu
Providing the most accurate clinically-driven interpretation of genetic variants in a timely manner MORL Clinical Diagnostic Services
The Molecular Otolaryngology and Renal Research Laboratory (MORL) is a CLIA approved, Joint Commission accredited diagnostic laboratory with a technical expertise in clinical genetic testing and interpretation. MORL Certifications and Licensure
What does it mean to get your testing done at the MORL? Testing at MORL
Working to increase our knowledge base of non-syndromic hearing loss and complement-mediated renal disease, including the development of new treatment options for both hearing loss, aHUS and C3G. Research at MORL


Ordering Genetic Hearing Loss Testing	Ordering Genetic Renal Panel Testing	Ordering Complement Functional Testing
OtoSCOPE provides comprehensive genetic testing for all genes implicated in non-syndromic hearing loss and many types of syndromic hearing loss. An Usher Syndrome Panel is also available.	The Genetic Renal Panel tests for genetic causes of TMA (aHUS and TTP) and C3G (DDD and C3GN). The Panel includes analysis for complex genomic rearrangements of the CFHR region.	Comprehensive complement testing includes quantitating complement proteins and their cleavage products, measuring complement activity, and screening for autoantibodies.

Your results are discussed at a multidisciplinary meeting.
Your testing is performed in the Clinical Division of the MORL by scientists who lead the world in the human genetics of deafness and complement-mediated renal diseases.
Our testing is the most comprehensive clinical testing available.